PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 106 filers reported holding PMV PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,333,302 | -5.9% | 542,883 | -4.1% | 0.00% | 0.0% |
| Q2 2023 | $3,542,803 | -14.6% | 565,943 | -35.0% | 0.00% | 0.0% |
| Q1 2023 | $4,150,158 | -42.1% | 870,054 | +5.5% | 0.00% | 0.0% |
| Q4 2022 | $7,173,760 | -44.9% | 824,570 | -24.6% | 0.00% | -66.7% |
| Q3 2022 | $13,008,000 | -19.1% | 1,093,116 | -3.1% | 0.00% | 0.0% |
| Q2 2022 | $16,083,000 | +1098.4% | 1,128,567 | +1650.9% | 0.00% | – |
| Q1 2022 | $1,342,000 | +85.4% | 64,456 | +105.7% | 0.00% | – |
| Q4 2021 | $724,000 | -97.8% | 31,337 | -96.8% | 0.00% | -100.0% |
| Q2 2021 | $33,148,000 | +0.0% | 970,364 | -3.7% | 0.01% | 0.0% |
| Q1 2021 | $33,144,000 | -58.2% | 1,007,723 | -22.8% | 0.01% | -60.0% |
| Q4 2020 | $79,230,000 | +38.7% | 1,305,179 | -20.7% | 0.02% | +25.0% |
| Q3 2020 | $57,139,000 | – | 1,645,822 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |